SCHEMBL4510892

SCHEMBL4510892

Cc1scc2c1c(O)c(C(=O)N(C)c1ccccc1)c(=O)n2C

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.63
MEN1 O00255 5/20 0.63
PGR P06401 1/20 0.63
HDAC4 P56524 1/20 0.48
SRC P12931 1/20 0.46
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 2/20 0.39
TP53 P04637 2/20 0.36
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
GNRHR P30968 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
LMNA P02545 1/20 0.35
HIF1A Q16665 1/20 0.35
ERCC5 P28715 1/20 0.35
POLB P06746 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4504478 0.92 MEN1 (0.52) KMT2AMEN1PGRHDAC4SRC
SCHEMBL4496044 0.89 MEN1 (0.49) KMT2AMEN1PGRHDAC4SRC
SCHEMBL4509464 0.87 HDAC4 (0.52) KMT2AMEN1PGRHDAC4SRC
SCHEMBL4512590 0.86 HDAC4 (0.63) KMT2AMEN1PGRHDAC4SRC
SCHEMBL4506519 0.85 MEN1 (0.46) KMT2AMEN1PGRHDAC4ALDH1A1
SCHEMBL5238949 0.83 HDAC4 (0.51) KMT2AMEN1PGRHDAC4ALDH1A1
SCHEMBL4509473 0.81 KMT2A (0.57) KMT2AMEN1PGRHDAC4SRC
SCHEMBL5167153 0.81 MEN1 (0.70) KMT2AMEN1PGRHDAC4SRC
SCHEMBL4510344 0.81 KMT2A (0.56) KMT2AMEN1PGRHDAC4SRC
SCHEMBL4496687 0.81 KMT2A (0.56) KMT2AMEN1PGRHDAC4SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP claimed
EP-1776369-A1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE Active Biotech AB (SE) 2007-04-25 EP claimed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US claimed
WO-2005123744-A1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2005-12-29 WO claimed
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US disclosed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP disclosed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004038-A1 Novel compounds REL, CLIC4, C5 KMT2A 4071/4885MEN1 509/4885PGR 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.